Plain-English translation of NCT06753136 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing electrochemotherapy — a treatment that combines electric pulses with a chemotherapy medication called Bleomycin — to treat cancers that have developed inside the body, such as in the liver, pancreas, or abdomen. The electric pulses help the chemotherapy medication work better by opening up cancer cells so the medication can enter them more effectively. Doctors will perform this treatment through a small needle, scope, or surgical opening, depending on where your tumor is located.
Many patients with internal cancers cannot safely have traditional surgery, but they still need effective treatment options. This trial is testing whether combining electric pulses with chemotherapy could be a helpful alternative that destroys these tumors while being easier on the body than major surgery.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will receive electrochemotherapy treatment within one month of enrolling. The procedure will be performed by inserting a needle through your skin, using a scope, or through a small surgical opening — depending on where your tumor is located. After treatment, you will have follow-up visits every two weeks for the first month to check how you're responding, and then once a month for up to 12 months total to monitor your recovery and how well the treatment is working.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Italy